Melatonin may help treat blood cancersSeptember 01, 2017
Researchers have examined the potential benefits of melatonin, a hormone made by a small gland in the brain, for treating blood cancers such as leukemia and lymphoma. They point to evidence that melatonin boosts the immune response against cancer cells, inhibits cancer cell growth, and protects healthy cells from the toxic effects of chemotherapy.
Because melatonin is also involved in regulating circadian rhythms, which help coordinate and synchronize internal body functions, timing of melatonin treatments may be critical to their anticancer effects.
"We hope this information will be helpful in the design of studies related to the therapeutic efficacy of melatonin in blood cancers," said Dr. Yang Yang, senior author of the British Journal of Pharmacology article. "Also, clarifying the mechanisms of melatonin's anticancer actions will help facilitate future basic research and clinical applications."
Related Leukemia Articles:
Researchers at The Australian National University (ANU) are working on a new treatment for an aggressive type of leukemia that outperforms standard chemotherapies.
UT Health San Antonio researchers discovered epigenetic changes that contribute to one-fifth of cases of acute myeloid leukemia (AML), an aggressive cancer that arises out of the blood-forming cells in bone marrow.
Watanabe-Smith's research, published today in the journal Oncotarget, sought to better understand one 'typo' in a standard leukemia assay, or test.
Scientists have discovered the genetic driver of a lethal childhood leukemia that affects newborns and infants and identified a targeted molecular therapy that halts the proliferation of leukemic cells.
Cancer researchers at the University of Cincinnati College of Medicine have found an obesity-associated protein's role in leukemia development and drug response which could lead to more effective therapies for the illness.
Dr. Irmela Jeremias from Helmholtz Zentrum München and her colleagues have succeeded in finding a small population of inactive leukemia cells that is responsible for relapse of the disease.
A team of UCLA bioengineers has demonstrated that its technology may go a long way toward overcoming the challenges of treatment for acute lymphoblastic leukemia, among the most common types of cancer in children, and has the potential to help doctors personalize drug doses.
Cancer cells need a lot of energy in order to divide without limits.
For the first time, researchers have discovered that some leukemia cells harvest energy resources from normal cells during chemotherapy, helping the cancer cells not only to survive, but actually thrive, after treatment.
In this issue of JCI Insight, Nicholas Chiorazzi and colleagues at the Feinstein Institute for Medical Research sought to understand a model of chronic lymphocytic leukemia in which patient cancer cells are transplanted into immunocompromised mice.
Related Leukemia Reading:
Leukemia: From Diagnosis to Winning the Battle
by Ryan Woelfel (Author), MD Robert Brian Berryman (Foreword), Connie Kouba (Foreword)
You’re a young 24-year-old, three months out of college, working as a Systems Engineer for a company, at a salary you named. You’re engaged to be married in a month, closing on a house and on top of the world, and that world has just been turned upside down. You’ve just been diagnosed with cancer – leukemia. Now what? So much uncertainty. In fact, the only certainty is just how uncertain everything is. But wait. Maybe there’s a reason for all this. Maybe some underlying purpose. Maybe this was all part of some greater plan.
This is the personal account of one... View Details
Leukemia (The Biology of Cancer)
by Donna M. Bozzone (Author)
Leukemia, or cancer of the blood or bone marrow, occurs in both acute and chronic forms. While the exact causes of the disease are not known, several risk factors have been identified. There are four major types of leukemia: acute myeloid leukemia (AML), chronic myeloid leukemia (CML), acute lymphoid leukemia (ALL), and chronic lymphoid leukemia (CLL), and treatments include chemotherapy, radiation, and bone marrow transplants. Leukemia discusses the science of leukemia, theories about its causes, the history of the disease, and the current treatments and how they work. View Details
Acute Leukemia: An Illustrated Guide to Diagnosis and Treatment
by Ashkan Emadi MD PhD (Editor), Judith E. Karp MD (Editor)
Acute Leukemia: An Illustrated Guide to Diagnosis and Treatment provides a comprehensive and concise visual reference on acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) seen in children and adults.
This book addresses all aspects of AML and ALL including their risk factors, cytogenetics and mutational characteristics, diagnoses, clinical management and prognoses which are imperative and challenging for medical students, residents, hematology and medical oncology fellows, and even community oncologists and hematologists. It presents complex information... View Details
Childhood Leukemia: A Guide for Families, Friends & Caregivers (Childhood Cancer Guides)
by Nancy Keene (Author)
Approximately 3,300 children are diagnosed with leukemia in the United States each year. The illness and its treatment can have a devastating effect on family, friends, schoolmates, and the larger community. This newly updated edition of Childhood Leukemia contains the information and support parents need during this difficult time. Author Nancy Keene provides parents and family members with: • Updates on treatment, including stem cell transplants, information about tailoring drugs dosages to children’s genetic profiles, and new methods for dealing with side effects. • Practical advice... View Details
100 Questions & Answers About Leukemia
by Edward D. Ball (Author), Alex Kagan (Author)
Whether you're a newly diagnosed patient, survivor, or a friend, relative or caregiver, 100 Questions & Answers About Leukemia offers support and guidance. Now in its third edition, 100 Questions & Answers About Leukemia continues the successful doctor-patient collaboration, providing authoritative, practical answers to your questions regarding diagnostic testing, treatment options, clinical trials and much more.
Written by a leukemia survivor and a prominent physician specializing in treatment of leukemia, this book is an invaluable resource for anyone coping... View Details
NCCN Guidelines for Patients®: Chronic Lymphocytic Leukemia, 2018
by National Comprehensive Cancer Network® (NCCN®) (Author)
From the medical leaders of 27 leading cancer centers united under the National Comprehensive Cancer Network® (NCCN®), comes this essential guide to chronic lymphocytic leukemia (CLL). Adapted from clinical treatment guidelines used by physicians and oncology professionals around the world, these NCCN Guidelines for Patients® are packed with the latest information, treatment innovations, and resources about the diagnosis and treatment of CLL. Each patient-friendly chapter prepares patients and caregivers to talk with their doctors and make treatment decisions. Let this authoritative... View Details
Six Years and Counting: Love, Leukemia, and the Long Road Onward
by Peter Gordon (Author)
A bone marrow transplant and beyond: an American healthcare odyssey
Having rebuilt his life after a painful divorce, Peter was on top of the world. Recently remarried, a thriving career, living in a beautiful mountain resort, at the peak of fitness and health - life was looking up again. Suddenly an aggressive case of acute leukemia seized his body and turned his world upside down. His only hope for survival was a bone marrow transplant, and at his age the outlook wasn't good...
In this gripping chronicle, Peter Gordon describes the initial shock of his diagnosis,... View Details
The Philadelphia Chromosome: A Genetic Mystery, a Lethal Cancer, and the Improbable Invention of a Lifesaving Treatment
by Jessica Wapner (Author), Robert A. Weinberg PhD (Foreword)
Philadelphia, 1959: A scientist scrutinizing a single human cell under a microscope detects a missing piece of DNA. That scientist, David Hungerford, had no way of knowing that he had stumbled upon the starting point of modern cancer research― the Philadelphia chromosome. It would take doctors and researchers around the world more than three decades to unravel the implications of this landmark discovery. In 1990, the Philadelphia chromosome was recognized as the sole cause of a deadly blood cancer, chronic myeloid leukemia, or CML. Cancer research would never be the same.
Leukemia (WHAT YOU NEED TO KNOW Book 7)
Definition of leukemia: Cancer that starts in blood-forming tissue such as the bone marrow and causes large numbers of blood cells to be produced and enter the bloodstream.
Estimated new cases and deaths from leukemia in the United States in 2012:
New cases: 47,150
Deaths: 23,540 View Details
Leukemia (Perspectives on Diseases and Disorders)
by Adrienne Wilmoth Lerner (Author)
Each volume in this series explores a particular disease or disorder in detail, beginning with an overview chapter that covers symptoms, causes and effects, treatments, cures, and medical advances; a chapter presenting numerous pro/con essays on the controversies surrounding the disease or disorder; and a final chapter containing engaging first-person accounts from people coping with the disease. View Details